Prosecution Insights
Last updated: October 04, 2026

Shanghai Ruiyu Biotech Co. Ltd.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Analysis

Shanghai Ruiyu Biotech Co. Ltd. currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 3 distinct examiners and 3 distinct art units. This distribution indicates that each pending matter is being handled by a different individual in a different organizational unit of the patent office.

DULANEY, KATHLEEN YUAN is identified as the busiest examiner for the portfolio, with 1 pending office action. The remaining volume of pending actions is handled by the other examiners, ensuring that no single examiner dominates the company's prosecution pipeline. With 3 pending office actions in total, the workload is spread across several individuals.

The involvement of 3 distinct art units suggests that the Biotechnology & Pharmaceuticals applications cover diverse technical subjects. Each of the pending office actions requires a unique response strategy tailored to the specific examiner and art unit. With 1 pending action per examiner, the company must manage several separate interactions to advance its portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)3 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DULANEY, KATHLEEN YUAN 1 77.0% +24.3%
BATES, KEENAN ALEXANDER 1 45.5% +79.5%
ABEL, LENORA A 1 68.3% +34.5%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18540799 METHOD AND SYSTEM FOR DETERMINING MIGRATION CAPACITY OF CELLS DULANEY, KATHLEEN YUAN —
18477543 CULTURE DEVICES AND METHODS BATES, KEENAN ALEXANDER —
18462393 SAMPLE ANALYSIS DEVICES AND SYSTEMS ABEL, LENORA A —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18540799 METHOD AND SYSTEM FOR DETERMINING MIGRATION CAPACITY OF CELLS DULANEY, KATHLEEN YUAN —
18477543 CULTURE DEVICES AND METHODS BATES, KEENAN ALEXANDER —
18462393 SAMPLE ANALYSIS DEVICES AND SYSTEMS ABEL, LENORA A —

Top Art Units

Art UnitApps
1657 1
1631 1
1799 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18540799 METHOD AND SYSTEM FOR DETERMINING MIGRATION CAPACITY OF CELLS DULANEY, KATHLEEN YUAN 1657 §102§103§112 Non-Final OA — Pending Dec 14, 2023
18477543 CULTURE DEVICES AND METHODS BATES, KEENAN ALEXANDER 1631 §102§103 Non-Final OA — Pending Sep 28, 2023
18462393 SAMPLE ANALYSIS DEVICES AND SYSTEMS ABEL, LENORA A 1799 §102§103 Non-Final OA — Pending Sep 06, 2023

Managing Shanghai Ruiyu Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month